MapLight Therapeutics

IPO

Creating breakthrough innovative therapeutics for serious CNS disorders

Public · San Francisco, United States · Founded 2018 · $372.5M raised

Employees
51–200
Founded
2018
Business Model
Other
Total Funding
$372.5M
Last Round
$372.5M Series DJul 2025
Rounds
1
Type
Public

About

MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics for central nervous system (CNS) disorders using an integrated computational and experimental platform.

Summary

MapLight Therapeutics is an Artificial Intelligence company based in San Francisco, United States, founded in 2018. It has raised $372.5M in total across 1 round, most recently a $372.5M Series D round in Jul 2025. Investors include Forbion Capital Partners and Novo Holdings A/S.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOOct 2025
$258.9M

Sign up to see all 2 rounds

Series D through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MapLight Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/maplight-therapeutics"><img src="https://indexed.vc/api/badge/company/maplight-therapeutics" alt="MapLight Therapeutics on Indexed.vc" width="260" height="76" /></a>